Lithium Side Effects in the Medically Ill

Abstract

Objective:

This review will include the general pharmacology of lithium and discuss its effects on various organ systems, with emphasis on the medically ill patient as well as the geriatric patient with multiple medical problems.

Methods:

A full literature review on the side effects of lithium was performed. Attention is focused on the medically ill and possible drug interactions.

Results:

This review points to the numerous problems which can result in toxicity in the medically ill or the geriatric patient.

Conclusion:

Serious side effects can be avoided with proper drug monitoring and knowledge of potential drug interactions.

Keywords

lithium side effects drug interactions medically ill toxicity

Get full access to this article

View all access options for this article.

References

Norton

and Whalley

J. L.

Mortality of a Lithium Treated Population, The British Journal of Psychiatry, 145: 277–282, 1984.

Vestergaard

and Aagaard

Five-Year Mortality in Lithium-Treated Manic-Depressive Patients, Journal of Affective Disorders, 21: 33–38, 1991.

Guze

S. B.

and Robins

Suicide and Primary Affective Disorder, The British Journal of Psychiatry, 117: 437–438, 1970.

Stern

T. A.

and Lydiard

R. B.

Lithium Therapy Revisited, Psychiatric Medicine, 4: 39–68, 1987.

Shou

Lithium Prophylaxis: Myths and Realities, The American Journal of Psychiatry, 146: 573–576, 1989.

Foster

J. R.

Use of Lithium in Elderly Psychiatric Patients: A Review of the Literature, Lithium, 3: 77–93, 1992.

Gelenberg

A. J.

Kane

J. M.

Keller

M. B.

Combination of Standard and Low Serum Levels of Lithium for Maintenance Treatment of Bipolar Disorder, The New England Journal of Medicine, 321: 1489–1493, 1989.

Kropf

and Muller-Verlinghausen

Changes in Learning, Memory, and Mood During Lithium Treatment, Acta Psychiatrica Scandinavica, 59: 97–124, 1979.

Karnoil

I. G.

Dalton

, and Lader

M. H.

Acute and Chronic Effects of Lithium Chloride on Physiological and Psychological Measures in Normals, Psychopharmacology, 57: 289–294, 1978.

10.

Jarrett

D. B.

Serry

, and Burrows

G. D.

, Lithium-Induced Tremor, Medical Journal of Australia, 1: 21, 1975.

11.

Schou

Baastrup

P. C.

Grof

Weis

, and Angst

Pharmacological and Clinical Problems of Lithium Prophylaxis, British Journal of Psychiatry, 116: 615–619, 1970.

12.

Vestergaard

Amdisen

, and Schou

Clinically Significant Side Effects of Lithium Treatment: A Survey of 237 Patients in Long-Term Treatment, Acta Psychiatrica Scandinavica, 62: 193–200, 1980.

13.

Carroll

J. A.

Jefferson

J. W.

, and Griest

J. H.

Treating Tremor Induced by Lithium, Psychopharmacology, 38: 1280–1281, 1987.

14.

Vacaflor

, Lithium Side Effects and Toxicity: The Clinical Picture, in Lithium Research and Therapy, Johnson

F. N.

(ed.), Academic Press, New York, pp. 211–216, 1975.

15.

Ghadirian

A. M.

and Lehmann

H. E.

Neurological Side Effects of Lithium: Organic Brain Syndrome, Seizures, Extrapyramidal Side Effects, and EEG Changes, Comprehensive Psychiatry, 21: 327–335, 1980.

16.

Shopsin

and Gershon

Cogwheel Rigidity Related to Lithium Maintenance, The American Journal Psychiatry, 132: 536–538, 1975.

17.

Bien

R. D.

Cogwheel Rigidity Early in Lithium Therapy, The American Journal of Psychiatry, 133: 1093–1094, 1976.

18.

Jefferson

J. W.

Greist

J. W.

Ackerman

D. L.

, and Carroll

J. A.

, Lithium Encyclopedia for Clinical Practice, 2nd Edition, American Psychiatric Press, Washington, pp. 361–370, 1987.

19.

Gerson

and Yuwiler

Lithium ion: A Specific Psychopharmacological Approach to the Treatment of Mania, Journal of Neuropsychiatry, 1: 229–241, 1960.

20.

Baldessarini

R. J.

and Stephens

J. H.

Lithium Carbonate for Affective Disorders, I. Clinical Pharmacology and Toxicology, Archives of General Psychiatry, 22: 72–77, 1970.

21.

Erwin

C. W.

Gerber

C. J.

Morrison

S. D.

, and James

J. F.

Lithium Carbonate and Convulsive Disorders, Archives of General Psychiatry, 28: 646–648, 1973.

22.

Shukla

Mukherjee

, and Decina

Lithium in the Treatment of Bipolar Disorders Associated with Epilepsy: An Open Study, Journal of Clinical Psychopharmacology, 8: 201–204, 1988.

23.

Rifkin

Quitkin

, and Klein

D. F.

Organic Brain Syndrome During Lithium Carbonate Treatment, Comprehensive Psychiatry, 143: 251–254, 1973.

24.

Vacaflor

Lehman

H. E.

, and Ban

T. A.

Side Effects and Teratogenicity of Lithium Carbonate Treatment, Journal of Clinical Pharmacology, 10: 387–389, 1970.

25.

Shopsin

and Gershon

, Pharmacology-Toxicology of the Lithium Ion, in Lithium Its Role in Psychiatric Research and Treatments, Gershon

and Shopsin

(eds.), Plenum Press, New York, pp. 107–146, 1973.

26.

Cohen

W. J.

and Cohen

N. H.

Lithium Carbonate, Haloperidol, and Irreversible Brain Damage, Journal of the American Medical Association, 230: 1283–1287, 1974.

27.

Marhold

Zimanova

Lachman

Kral

, and Vojtechovsky

To the Incompatibility of Haloperidol with Lithium Salts, Activitas Nervosa Superior (Praha), 16: 199–200, 1974.

28.

Thornton

W. E.

and Pray

B. J.

Lithium Intoxication—A Report of Two Cases, The Canadian Psychiatric Association Journal, 20: 281–282, 1975.

29.

Singer

and Rotenberg

Mechanisms of Lithium Action, The New England Journal of Medicine, 289: 254–260, 1973.

30.

Rabin

E. Z.

Garston

R. G.

Levitan

S. J.

, and Blumberg

A. G.

Lithium-Induced Diabetes Insipidus-Like Syndrome, Comprehensive Psychiatry, 11: 141–146, 1970.

31.

Rabin

E. Z.

Garston

R. G.

Weir

R. V.

, and Posen

G. A.

Persistent Nephrogenic Diabetes Insipidus Associated with Long-Term Lithium Carbonate Therapy, The Canadian Medical Association Journal, 121: 194–198, 1979.

32.

Hetmar

Bolwig

T. O.

Brun

Ladefoged

Larsen

, and Rafaelsen

O. J.

Lithium: Long-Term Effects on the Kidney. I. Renal Function in Retrospect, Acta Psychiatrica Scandinavica, 73: 574–581, 1986.

33.

Himmelhoch

J. M.

Proust

R. I.

Mallinger

A. G.

Adjustment of Lithium Dose During Lithium-Chlorothiazide Therapy, Clinical Pharmacology and Therapeutics, 22: 225–227, 1977.

34.

Bendz

Kidney Function in Lithium Treated Patients: A Literature Survey, Acta Psychiatrica Scandinavica, 68: 303–324, 1983.

35.

DasGupta

and Jefferson

J. W.

The Use of Lithium in the Medically Ill, General Hospital Psychiatry, 12: 83–97, 1990.

36.

Hestbech

Hansen

H. E.

Amdisen

, and Olsen

Chronic Renal Lesions Following Long-Term Treatment with Lithium, Kidney International, 12: 205–213, 1977.

37.

Bucht

Wahlin

Wentzel

, and Winblad

Renal Function and Morphology in Long-Term Lithium and Combined Lithium-Neuroleptic Treatment, Acta Medica Scandinavica, 208: 381–385, 1980.

38.

Hansen

H. E.

Hestbech

Sørensen

J. L.

Onørgaard

Heilskov

, and Amdisen

Chronic Interstitial Nephropathy in Patients in Long-Term Lithium Treatment, Quarterly Medical Review (New Series), 48: 577–591, 1979.

39.

Bakris

G. L.

Taylor

M. A.

Mulopulos

G. P.

, and Wawczk

Lithium Prophylaxis and the Kidney, Journal of Affective Disorders, 3: 37–42, 1981.

40.

Schou

and Vestergaard

Prospective Studies on a Lithium Cohort 2. Renal Function, Water and Electrolyte Metabolism, Acta Psychiatrica Scandinavica, 78: 427–433, 1988.

41.

Boton

Gaviria

, and Batlle

D. C.

, Prevalence, Pathogenesis, and Treatment of Renal Dysfunction Associated with Chronic Lithium Therapy, American Journal of Kidney Diseases, X: 329–345, 1987.

42.

Vaamonde

C. A.

Milian

N. E.

, and Magrinat

G. S.

, Longitudinal Evaluation of Glomerular Filtration Rate During Long-Term Lithium Therapy, American Journal of Kidney Diseases, IX: 213–216, 1986.

43.

DePaulo

J. R.

Jr. Lorrea

E. I.

, and Sapir

D. G.

Renal Glomerular Function and Long-Term Lithium Therapy, The American Journal of Psychiatry, 138: 324–327, 1981.

44.

Jensen

H. V.

Olafsson

Bille

Anderson

Mellerup

, and Plenge

Lithium Every Second Day: A New Treatment Regimen?, Lithium, 1: 55–58, 1990.

45.

Coppen

Bishop

M. E.

Bailey

J. E.

Cattell

W. R.

, and Price

R. G.

Renal Function in Lithium and Non-Lithium-Treated Patients with Affective Disorders, Acta Psychiatrica Scandinavica, 62: 343–355, 1980.

46.

Moskovitz

Springer

, and Urguhart

Lithium-Induced Nephrotic Syndrome, The American Journal of Psychiatry, 138: 382–383, 1981.

47.

Richman

A. V.

Masco

H. L.

Rifkin

S. I.

, and Acharya

M. K.

Minimal-Change Disease and the Nephrotic Syndrome Associated with Lithium Therapy, Annals of Internal Medicine, 92: 70–72, 1980.

48.

Csernansky

J. G.

and Hollister

L. E.

Using Lithium in Patients with Cardiac and Renal Disease, Hospital Formulary, 20: 726–735, 1985.

49.

Procci

W. R.

Mania During Maintenance Hemodialysis Successfully Treated with Oral Lithium Carbonate, The Journal of Nervous and Mental Disease, 164: 355–358, 1977.

50.

Koecheler

J. A.

Canafax

D. M.

Simmons

R. L.

Lithium Dosing in Renal Allograft Recipients with Declining Renal Function, Drug Intelligence and Clinical Pharmacy, 20: 623–624, 1986.

51.

Ausiello

D. A.

and Kiprov

Renal Failure in a 29-Year Old Man with Manic Psychosis, The New England Journal of Medicine, 304: 1025–1032, 1981.

52.

Rosenbaum

J. F.

and Pollack

M. H.

Treatment-Emergency Incontinence with Lithium, Journal of Clinical Psychiatry, 46: 444–456, 1985.

53.

Schou

Amdisen

Eskajaer-Jensen

, and Olsen

Occurrence of Goiter During Lithium Treatment, The British Medical Journal, 3: 710–713, 1968.

54.

Perrild

Hegedüs

Baastrup

P. C.

Kayser

, and Kastberg

Thyroid Function and Ultrasonically Determined Thyroid Size in Patients Receiving Long-Term Lithium Treatment, The American Journal of Psychiatry, 147: 1518–1521, 1990.

55.

Baldessarini

R. J.

Lipinski

J. F.

Lithium Salts: 1970–75, Annals of Internal Medicine, 83: 527–533, 1975.

56.

Emerson

C. H.

Dyson

W. L.

, and Utiger

R. D.

Serum Thyrotropin and Thyroxine Concentration in Patients Receiving Lithium Carbonate, Journal of Clinical Endocrinology and Metabolism, 36: 338–346, 1973.

57.

Jefferson

J. W.

Lithium Carbonate-Induced Hypothyroidism—Its Many Faces, Journal of the American Medical Association, 242: 271–272, 1979.

58.

Jefferson

J. W.

Greist

J. H.

Ackerman

D. L.

, and Carroll

J. A.

, Lithium Encyclopedia for Clinical Practice, 2nd Edition, American Psychiatric Press, Washington, pp. 352–355, 1987.

59.

Colt

E. W. D.

Kimbrell

, and Fieve

Renal Impairment, Hypercalcemia, and Lithium Therapy, The American Journal of Psychiatry, 138: 106–109, 1981.

60.

Christensson

T. A. T.

Lithium, Hypercalcemia, and Hyperparathyroidism, The Lancet, 2: 969, 1976.

61.

Prasad

Chronic Lithium Intake and Hyperparathyroidism, European Journal of Clinical Pharmacology, 27: 499–500, 1984.

62.

Heninger

G. R.

and Mueller

P. E.

Carbohydrate Metabolism in Mania: Before and After Treatment with Lithium Carbonate, Archives of General Psychiatry, 23: 310–319, 1970.

63.

Shopsin

Stern

, and Gerson

Altered Carbohydrate Metabolism During Treatment with Lithium Carbonate, Acta Psychiatrica Scandinavica, 53: 64–69, 1972.

64.

Vendsborg

P. B.

and Pryatz

Glucose Tolerance and Serum Lipids in Man After Long-Term Lithium Administration, Acta Psychiatrica Scandinavica, 53: 64–69, 1976.

65.

Schou

Electrocardiographic Changes During Treatment with Lithium and With Drugs of the Imipramine-Type, Acta Psychiatrica Scandinavica (Suppl), 169: 258–259, 1963.

66.

Brady

H. R.

and Horgan

J. H.

Lithium and the Heart, Unanswered Questions, Chest, 93: 166–169, 1988.

67.

Roose

S. P.

Nurnberger

J. I.

Dunner

D. L.

Blood

D. K.

, and Fieve

R. R.

Cardiac Sinus Node Dysfunction During Lithium Treatment, The American Journal of Psychiatry, 136: 804–806, 1979.

68.

Jefferson

J. W.

Greist

J. W.

Ackerman

D. L.

, and Carroll

J. A.

, Lithium Encyclopedia for Clinical Practice, 2nd Edition, American Psychiatric Press, Washington, pp. 175–176, 1987.

69.

Jafee

C. M.

First-Degree Atrioventricular Block During Lithium Carbonate Treatment, The American Journal of Psychiatry, 134: 88–89, 1977.

70.

Worthley

L. I. C.

Lithium Toxicity and Refractory Cardiac Arrhythmia Treated with Intravenous Magnesium, Anesthesia and Intensive Care, 2: 357–360, 1974.

71.

Tseng

H. L.

Interstitial Myocarditis Probably Related to Lithium Carbonate Intoxication, Archives of Pathology, 92: 444–448, 1971.

72.

Swedberg

and Winblad

Heart Failure as a Complication of Lithium Treatment, Acta Medica Scandinavica, 196: 279–280, 1974.

73.

Stancer

H. C.

and Kivi

Lithium Carbonate and Oedema, The Lancet, 2: 985, 1971.

74.

Prindle

J. H.

Jr. Gold

H. K.

, and Cardon

P. V.

Effects of Psychopharmacologic Agents on Myocardial Contractility, Journal of Pharmacology and Experimental Therapeutics, 173: 133–137, 1970.

75.

Hanus

Bily

Hametova

, Rare Complications in Lithium Therapy: Two Case Reports, Activitas Nervosa Superior (Praha), 14: 105, 1972.

76.

Mattsson

and Seltzer

R. L.

Lithium Carbonate and Gastric Ulcer, The American Journal of Psychiatry, 138: 124, 1981.

77.

Muniz

C. E.

and Berghman

D. H.

Contact Stomatitis and Lithium Carbonate Tablets, Journal of the American Medical Association, 239: 2759, 1978.

78.

Vasile

R. G.

and Shelton

R. P.

Alleviating Gastrointestinal Side Effects of Lithium Carbonate by Substituting Lithium Citrate, Journal of Clinical Psychopharmacology, 2: 420–424, 1982.

79.

Tisman

and Wu

S. G.

, Haematological Side-Effects of Lithium, in Handbook of Lithium Therapy, Johnson

F. N.

(ed.), University Park Press, Baltimore, p. 339, 1980.

80.

Tisman

Herbert

, and Rosenblatt

Evidence that Lithium Induces Human Granulocyte Proliferation: Elevated Serum Vitamin B12 Binding Capacity In Vivo and Granulocyte Colony Proliferation In Vitro, British Journal of Haematology, 24: 767–771, 1973.

81.

Richman

C. M.

Makii

M. M.

Weiser

P. A.

, and Herbst

A. L.

The Effects of Lithium Carbonate on Chemotherapy-Induced Neutropenia and Thrombocytopenia, American Journal of Hematology, 16: 313–323, 1984.

82.

Friedenberg

W. R.

and May

J. J.

Jr. The Effect of Lithium Carbonate on Lymphocyte, Granulocyte and Platelet Function, Cancer, 45: 91–97, 1980.

83.

Hammond

W. P.

and Appelbaum

, Lithium and Acute Monocytic Leukemia, The New England Journal of Medicine, 302: 808, 1980.

84.

Nielson

J. L.

Development of Acute Myeloid Leukemia During Lithium Treatment, Acta Haematologica, 63: 172–173, 1980.

85.

Orr

L. E.

and McKernan

J. F.

Lithium Reinduction of Acute Myeloblasts Leukemia, The Lancet, 1: 449–450, 1979.

86.

Leber

Lithium Leukocytosis, and Leukemia: The Probable Influence of Biologic Plausibility on Clinical Concern, Psychopharmacology Bulletin, 17: 10–13, 1981.

87.

Lyskowski

and Nasiallah

N. A.

Lithium Therapy and the Risk for Leukemia, The British Journal of Psychiatry, 139: 256, 1981.

88.

Hussain

M. Z.

Khan

A. G.

, and Chaudhry

Z. A.

Aplastic Anemia Associated with Lithium Therapy, The Canadian Medical Association Journal, 108: 724–728, 1973.

89.

Prakash

Sethi

Agrawal

S. S.

Kushwahu

M. R. S.

, and Sethi

B. B.

A Case Report of Megaloblastic Anemia Secondary to Lithium, The American Journal of Psychiatry, 138: 49, 1981.

90.

Joffee

R. T.

Kellner

C. H.

Post

R. M.

, and Uhde

T. W.

Lithium Increases Platelet Count, The New England Journal of Medicine, 311: 674–675, 1984.

91.

Jefferson

J. W.

Greist

J. W.

Ackerman

D. L.

, and Carroll

J. A.

, Lithium Encyclopedia for Clinical Practice, 2nd Edition, American Psychiatric Press, Washington, p. 342, 1987.

92.

Gupta

R. K.

and Montgomery

Status of Lithium Patients as Blood Donors, The Lancet, 1: 860, 1975.

93.

Yoder

F. W.

Acneform Eruption due to Lithium Carbonate, Archives of Dermatology, 7: 396–397, 1975.

94.

Skoven

and Thormann

Lithium Compound Treatment and Psoriasis, Archives of Dermatology, 115: 1185–1187, 1979.

95.

Deandrea

Walker

Mehlmauer

Dermatological Reactions to Lithium: A Critical Review of the Literature, Journal of Clinical Psychopharmacology, 2: 199–204, 1982.

96.

Kurtin

S. B.

Lithium Carbonate Dermatitis, Journal of the American Medical Association, 223: 802, 1973.

97.

Posey

R. E.

Lithium Carbonate Dermatitis, Journal of the American Medical Association, 221: 1517, 1972.

98.

Kuhnley

E. J.

and Granoff

A. L.

Exfoliative Dermatitis During Lithium Treatment, The American Journal of Psychiatry, 136: 1340–1341, 1979.

99.

Amsterdam

J. D.

Maislin

Potter

, and Giuntoli

Reduced Rate of Recurrent Genital Herpes Infections with Lithium Carbonate, Psychopharmacology Bulletin, 26: 343–347, 1990.

100.

Pakes

G. E.

Eye Irritation and Lithium Carbonate, Archives of Ophthalmology, 98: 930, 1980.

101.

Pesando

Nuzzi

, and Maraini

Bilateral Papilledemia in Long-Term Therapy with Lithium Carbonate, Pharmakopsychiatrie, 13: 235–239, 1980.

102.

Demers

and Heninger

Pretibial Edema and Sodium Retention During Lithium Carbonate Treatment, Journal of the American Medical Association, 214: 1845–1848, 1970.

103.

Viegut

and Jefferson

J. W.

Lithium and the Liver, Lithium, 1: 9–13, 1990.

104.

Peselow

E. D.

Dunner

D. L.

, and Rieve

R. R.

Lithium Carbonate and Weight Gain, Journal of Affective Disorders, 2: 303–310, 1980.

105.

Chen

and Silverstone

Lithium and Weight Gain, International Clinical Psychopharmacology, 5: 217–225, 1990.

106.

Dempsey

G. M.

Dunner

D. L.

, and Fieve

R. R.

Treatment of Excessive Weight Gain in Patients Taking Lithium, The American Journal of Psychiatry, 133: 1082–1084, 1976.

107.

Garland

E. J.

Remick

R. A.

, and Zis

A. P.

Weight Gain with Antidepressants and Lithium, Journal of Clinical Psychopharmacology, 8: 323–330, 1988.

108.

MacFie

A. C.

Lithium Poisoning Precipitated by Diuretics, The British Medical Journal, 1: 516, 1975.

109.

Baer

Platman

S. R.

Kassir

Fieve

R. R.

Mechanisms of Renal Lithium Handling and Their Relationship to Mineralocorticoids: A Dissociation Between Sodium and Lithium Ions, Journal of Psychiatric Research, 8: 91–105, 1971.

110.

Baer

Glassman

A. H.

, and Kassir

Negative Sodium Balance and Lithium Carbonate Toxicity: Evidence of a Mineralocorticoid Blockade, Archives of General Psychiatry, 29: 823–827, 1973.

111.

Jefferson

J. W.

and Kalin

N. H.

Serum Lithium Levels and Long-Term Diuretic Use, Journal of the American Medical Association, 241: 1134–1136, 1979.

112.

Saffer

and Coppen

Frusemide: A Safe Diuretic During Lithium Therapy?, Journal of Affective Disorder, 5: 289–292, 1983.

113.

Battle

D. C.

vonRiotte

A. B.

Gaviria

Amelioration of Polyuria by Amiloride in Patients Receiving Long-Term Lithium Therapy, The New England Journal of Medicine, 312: 408–414, 1985.

114.

Thompsen

and Schou

Renal Lithium Excretion in Man, American Journal of Physiology, 215: 823–827, 1968.

115.

Valdiserri

E. V.

A Possible Interaction Between Lithium and Diltiazem: Case Report, Journal of Clinical Psychiatry, 46: 540–541, 1985.

116.

Price

W. A.

and Giannini

A. J.

Neurotoxicity Caused by Lithium-Verapamil Synergism, Journal of Clinical Pharmacology, 26: 717–719, 1986.

117.

Price

W. A.

and Shalley

J. E.

Lithium-Verapamil Toxicity in the Elderly, Journal of the American Geriatrics Society, 35: 177–179, 1987.

118.

Rostin

Livarek

Tordjman

, Angiotensin Converting Enzyme Inhibitors and Lithium Treatment, The Lancet, p. 1448, 1986.

119.

Navis

G. J.

deJong

P. E.

, and deZeeuw

Volume Homeostasis, Angiotensin Converting Enzyme Inhibition, and Lithium Therapy, The American Journal of Medicine, 86: 621, 1989.

120.

Ragheb

and Hayden

C. T.

The Clinical Significance of Lithium-Nonsteroidal Anti-Inflammatory Drug Interaction, Journal of Clinical Psychopharmacology, 10: 350–354, 1990.

121.

Spring

and Frankel

New Data on Lithium and Haloperidol Incompatibility, The American Journal of Psychiatry, 138: 818–821, 1981.

122.

Amdisen

Lithium and Drug Interactions, Drugs, 24: 133–139, 1982.

123.

Charney

D. S.

Kales

Soldatos

C. R.

, and Nelson

J. C.

Somnambulistic-Like Episodes Secondary to Combined Lithium-Neuroleptic Treatment, The British Journal of Psychiatry, 135: 418–424, 1979.

124.

Sletten

Pichardo

Korol

, and Gershon

The Effect of Chlorpromazine on Lithium Excretion in Psychiatric Subjects, Current Therapeutic Research, 8: 441–446, 1966.

125.

Rivera-Calimlin

Kerzner

, and Karch

F. E.

Effect of Lithium on Plasma Chloropromazine Level, Clinical Pharmacology and Therapeutics, 23: 451–455, 1978.

126.

Ostrow

D. G.

Southam

A. S.

, and Davis

J. M.

Lithium-Drug Interactions Altering the Intracellular Lithium Level: An In Vitro Study, Biological Psychiatry, 15: 723–739, 1980.

127.

Salama

A. A.

and Shaffey

A Case of Severe Lithium Toxicity Induced by Combined Fluoxetine and Lithium Carbonate, The American Journal of Psychiatry, 146: 278, 1989.

128.

Noveske

F. G.

Hahn

K. R.

, and Flynn

R. J.

Possible Toxicity of Combined Fluoxetine and Lithium, The American Journal of Psychiatry, 146: 1515, 1989.

129.

Sacristin

J. A.

Iglesias

Arellano

, and Lequerica

Absence Seizures Induced by Lithium: Possible Interaction with Fluoxetine, The American Journal of Psychiatry, 148: 146–147, 1991.

130.

Byrd

G. J.

Methyldopa and Lithium Carbonate: Suspected Interaction, Journal of the American Medical Association, 233: 320, 1975.

131.

O'Reagan

J. B.

Adverse Interaction of Lithium Carbonate and Methyldopa, The Canadian Medical Association Journal, 115: 385–386, 1976.

132.

Fankhauser

M. P.

Lindon

J. L.

Connolly

, and Healy

W. J.

Evaluation of Lithium-Tetracycline Interaction, Clinical Pharmacy, 7: 314–317, 1988.

133.

Borden

Clarke

M. T.

, and Katz

The Use of Pancuronium Bromide in Patients Receiving Lithium Carbonate, Canadian Anaesthist's Society Journal, 21: 79–82, 1974.

134.

Hill

G. F.

Wong

K. L.

, and Hodges

M. R.

Potentiation of Succinylcholine Neuromuscular Blockade by Lithium Carbonate, Anesthesiology, 44: 439–442, 1976.

135.

Anden

N. E.

Dalen

, and Johansson

Baclofen and Lithium in Huntington's Chorea, The Lancet, 2: 93, 1973.

136.

Cook

B. L.

Smith

R. E.

Perry

P. J.

Theophylline Precipitated Alterations of Lithium Clearance, Journal of Clinical Psychiatry, 46: 278–279, 1984.

137.

MacCullum

W. A. G.

Interaction of Lithium and Phenytoin, The British Medical Journal, 280: 610–611, 1980.

138.

Shukla

Godwin

C. D.

Long

L. E. B.

Lithium-Carbamazepine Neurotoxicity and Risk Factors, The American Journal of Psychiatry, 147: 1604–1606, 1984.

139.

Vieweg

Glick

J. L.

Herring

Absence of Carbamazepine-Induced Hyponatremia Among Patients also Given Lithium, The American Journal of Psychiatry, 144: 943–947, 1987.

140.

Joffe

R. T.

and Post

R. M.

Lithium and Carbamazepine-Induced Agranulocytosis, The American Journal of Psychiatry, 146: 404, 1989.

141.

Small

J. G.

and Milstein

Lithium Interactions: Lithium and Electroconvulsive Therapy, Journal of Clinical Psychopharmacology, 10: 346–350, 1990.

142.

Singer

(Principal Discussant) Lithium and the Kidney (Nephrology Forum), Kidney International, 19: 374–387, 1981.

143.

Strayhorn

J. M.

and Nash

J. L.

Severe Neurotoxicity Despite “Therapeutic” Serum Lithium Levels, Diseases of the Nervous System, 38: 107–111, 1977.

144.

Jensen

and Ladefogeds

Delayed Absorption of Lithium in Intoxication: A Case History, European Journal of Clinical Pharmacology, 8: 825, 1975.

145.

Schou

, The Recognition and Management of Lithium Intoxication, in Handbook of Lithium Therapy, Johnson

F. N.

(ed.), University Park Press, Baltimore, Maryland, pp. 394–402, 1980.

146.

Simard

Gumbiner

Lee

Lewis

, and Norman

Lithium Carbonate Intoxication: A Case Report and Review of the Literature, Archives of Internal Medicine, 149: 36–46, 1989.

147.

Amdisen

Clinical Features and Management of Lithium Poisoning, Medical Toxicology, 3: 18–32, 1988.

148.

Hansen

H. E.

and Amdisen

Lithium Intoxication, Quarterly Journal of Medicine, 47: 123–144, 1978.

149.

Gyulai

Wickland

S. W.

Greenstein

Bauer

M. S.

Ciccione

Whybrow

Zimmerman

Kovachich

, and Alves

Measurement of Tissue Lithium Concentration by Lithium Magnetic Resonance Spectroscopy in Patients With Bipolar Disorder, Biological Psychiatry, 29: 1161–1170, 1991.